Paridopa 50/12.5/200mg Tablet

Paridopa 50/12.5/200mg Tablet is a combination medication containing three active ingredients: Levodopa, Carbidopa, & Entacapone. It is prescribed for the management of Parkinson’s disease to improve the symptoms related to dopamine deficiency.

Components:

• Levodopa: Converts into dopamine in the brain, compensating for the reduced dopamine levels in Parkinson’s disease.
• Carbidopa: Enhances the effectiveness of Levodopa by preventing its breakdown in the bloodstream before it reaches the brain.
• Entacapone: Extends the duration of action of Levodopa by inhibiting its breakdown, providing more continuous relief of symptoms.

Uses:

Paridopa 50/12.5/200mg Tablet is indicated for the treatment of Parkinson’s disease, a progressive disorder affecting movement control. The combination of Levodopa, Carbidopa, and Entacapone helps manage motor symptoms such as tremors, stiffness, and slowness of movement.

Side Effects:

Common side effects may include nausea, vomiting, dyskinesias (involuntary movements), and hallucinations. Serious side effects are rare but may include orthostatic hypotension and psychiatric reactions. Report any unusual or severe side effects to your healthcare provider.

Precautions:

• Inform your healthcare provider about any pre-existing medical conditions, especially heart, liver, or kidney disorders.
• Disclose all medications, including prescription and over-the-counter drugs, as well as any herbal supplements, to avoid potential interactions.
• Regular monitoring may be required to adjust the dosage for optimal symptom control.

When Not to Use:

Paridopa 50/12.5/200mg Tablet may not be suitable for use in the following situations:

• Known hypersensitivity or allergy to Levodopa, Carbidopa, Entacapone, or any components of the tablet.
• Severe cardiovascular, hepatic, or renal disease.
• History of neuroleptic malignant syndrome (NMS) or non-traumatic rhabdomyolysis.